Mkts

Travere Therapeutics, Inc.

NASDAQ: TVTX
$51.56-0.48 (-0.92%)
As of Nov 12, 9:30 AM ET

Key statistics

Day range
51.1152.52
52-week range
22.5968.73
Today
Open51.79
Previous close51.56
Volume590.3K
Valuation
Market cap4.75B
P/E ratio—
EPS (TTM)-0.50
Income & risk
Dividend / yield—
Beta1.08
Avg volume2.45M
Discussion

TVTX News

Stories mentioning TVTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue127,199129,688164,859114,44981,73274,78762,89854,116
Cost of Goods Sold1,9502,5541,5851,5214,6792,5531,6262,061
Gross Profit125,249127,134163,274112,92877,05372,23461,27252,055
Operating Expenses
Research & Development
Sales General & Admin80,254114,12086,45376,21660,41369,50165,61964,776
Total Operating Expenses
Operating Income (Loss)(36,915)(32,431)24,931(12,650)(42,674)(60,737)(56,149)(67,704)
Interest Income2,5842,5923,0473,2873,7953,7953,5704,420
Interest Expense
Other Expense(91.00)11,068487.00(526.00)549.00(581.00)520.00(3,495)
Pretax Income(36,722)(21,065)25,714(12,735)(41,187)(60,340)(54,836)(69,567)
Tax Provision(120.00)921.008.0020.0039.00(72.00)(84.00)85.00
Net Income (Loss)(37,102)2,72925,706(12,755)(41,226)(60,264)(54,811)(70,409)
Earnings Per Share (Basic)(0.40)0.030.29(0.14)(0.47)(0.76)(0.70)(0.91)
Earnings Per Share (Diluted)(0.40)0.030.28(0.14)(0.47)(0.76)(0.70)(0.91)
Weighted Average Shares Outstanding (Basic)91,86989,21289,23088,94688,35678,88977,77977,500
Weighted Average Shares Outstanding (Diluted)91,86989,212102,61988,94688,35678,88977,77977,500

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TVTX

Travere Therapeutics, Inc. (NASDAQ: TVTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TVTX. It last traded at $51.56 (Nov 12, 2026, 9:30 AM ET), down 0.9% on the day. That gives Travere Therapeutics a market capitalisation of $4.7B.

Over the past 52 weeks TVTX has traded between $22.59 and $68.73.

Revenue for the quarter ended Mar 31, 2026 was $127.2M; a net loss of $37.1M. Revenue was up 55.6% from $81.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$127.2M-$37.1M-29.2%
Dec 31, 2025$129.7M$2.7M2.1%
Sep 30, 2025$164.9M$25.7M15.6%
Jun 30, 2025$114.4M-$12.8M-11.1%

From Travere Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…